1.
Intern Med J
; 46(8): 987-8, 2016 Aug.
Article
in English
| MEDLINE
| ID: mdl-27554002
2.
Intern Med J
; 45(9): 972-6, 2015 Sep.
Article
in English
| MEDLINE
| ID: mdl-26332623
ABSTRACT
Gastrointestinal haemorrhage from angiodysplastic lesions is not only difficult to identify, but often refractory to endoscopic intervention. Patients often require substantial transfusion support. Thalidomide has emerged as a promising medical strategy in angiodysplasia-related bleeding. We present our experience and report the findings from a review of the literature. Despite its side-effect profile, thalidomide remains the therapeutic modality with the best evidence in this difficult clinical scenario.